Skip to search formSkip to main contentSkip to account menu

12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule [Aggrenox]

Known as: Aggrenox 25/200 (aspirin 25 MG / dipyridamole 200 MG) 12HR Extended Release Oral Capsule, aspirin 25 mg / dipyridamole 200 mg ORAL CAPSULE [Aggrenox], Aggrenox 25/200 12HR Extended Release Oral Capsule 
National Institutes of Health

Related topics

Related topics

25 relations

Broader (1)

12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule
Acacia substanceAggrenoxAluminum stearateAspirin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Müssen Patienten Impfstoff besorgen?
! MMW-Experte Walbert: Diese Kombination von Dipyridamol und ASS ist zugelassen zur Sekundärprävention von Apoplex und… 
Review
2016
Review
2016
Vorapaxar monotherapy for secondary stroke prevention: A call for randomized trial
Background and Purpose Vorapaxar, a novel platelet thrombin protease-activated receptor 1 blocker, is currently approved for post… 
Review
2007
Review
2007
Aggrenox© (ASS+Dipyridamol) nach Schlaganfall besser als ASS 100 mg?
Introduction: For years now opinions have been divided as to the effectiveness of a combi- nation of Dipyramidol + ASS as… 
Review
2002
Review
2002
Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events
Aspirin has become an established therapy in patients for preventing recurrent stroke and the incidence of acute coronary events… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)